Journal of Microbiology

Randomized Controlled Trial

A split face study on the effect of an anti-acne product containing fermentation products of Enterococcus faecalis CBT SL-5 on skin microbiome modification and acne improvement: Hye Sung Han , Sun Hye Shin , Bo-Yun Choi , Nayeon Koo , Sanghyun Lim , Dooheon Son , Myung Jun Chung , Kui Young Park , Woo Jun Sul; J. Microbiol. 2022;60(5):488-495. Published online March 14, 2022; DOI: https://doi.org/10.1007/s12275-022-1520-6

104 View
0 Download
10 Web of Science
8 Crossref

Antibiotic-resistant Cutibacterium acnes and dysbiosis of the skin microbiome are of increasing concern in acne treatment. Enterococcus faecalis, a widely used probiotic, has shown benefits for acne treatment by exerting antimicrobial activity against C. acnes. Therefore, this study aimed to investigate the efficacy and safety of an E. faecalis CBT SL-5-extract-containing lotion in patients with mild-to-moderate acne. Twenty patients were enrolled in this randomized, placebo-controlled, split-face comparative study. Patients were treated with E. faecalis lotion on one side of the face and a vehicle lotion on the other side for 4 weeks. The efficacy outcome measures included improvement in the investigators’ assessment of acne severity, patient satisfaction, changes in skin parameters and diversity of the skin microbiome. The investigators’ assessment score was significantly improved on the test side compared to the control side, after 2 weeks (p = 0.009) and 6 weeks (p < 0.0005). However, TEWL and skin hydration were not significantly different between the two groups. The phylogenetic diversity of the skin microbiota decreased over time in the skin samples of test side. In conclusion, E. faecalis CBT SL-5 extract can be a feasible and well-tolerated option for improving acne severity and skin microbiome dysbiosis in mild-to-moderate acne patients.

Citations

Citations to this article as recorded by

Efficacy of a Postbiotic Formulation Combined With Microneedling for Mild‐to‐Moderate Acne: A Self‐Control Study
Zhanhong Li, Peihui Li, Yu Xu, Changqing Yan, Xiufen Ma, Huiying Wang, Hong Cheng, Jing Zeng, Ting Li, Xinxian Li, Jia Zhou, Jie Zhang, Jianfeng Zhou, Rongya Yang, Yan Wu, Li Li, Wei Lai, Jiangyun Zhao, Zhe Liu, Qiong Meng
Journal of Cosmetic Dermatology.2025;[Epub] CrossRef
Efficacy of Probiotic Supplements and Topical Applications in the Treatment of Acne: A Scoping Review of Current Results
Ida Ayu Manik Partha Sutema, Irma Latarissa, I Gusti Ayu Rai Widowati, Cynthia Retna Sartika, Ni Wayan Eka Ciptasari, Keri Lestari
Journal of Experimental Pharmacology.2025; Volume 17: 1. CrossRef
Acne vulgaris: advances in pathogenesis and prevention strategies
Weiping Xu, Jiahui Xu, Dandan Huang, Chen Wang, Jiajia Song, Xiaoyong Chen, Huayi Suo
European Journal of Clinical Microbiology & Infectious Diseases.2025; 44(3): 515. CrossRef
Analysis of global trends and hotspots of skin microbiome in acne: a bibliometric perspective
Lanfang Zhang, Yuan Cai, Lin Li, Jie Hu, Changsha Jia, Xu Kuang, Yi Zhou, Zhiai Lan, Chunyan Liu, Feng Jiang, Nana Sun, Ni Zeng
BioData Mining.2025;[Epub] CrossRef
Using probiotics to treat acne vulgaris: systematic review
Aleena Boby, Grace Lee, Nicole Natarelli, Lilia Correa
Archives of Dermatological Research.2024;[Epub] CrossRef
Skin Deep: The Potential of Microbiome Cosmetics
Ju Hee Han, Hei Sung Kim
Journal of Microbiology.2024; 62(3): 181. CrossRef
The updates and implications of cutaneous microbiota in acne
Cong Huang, Fan Zhuo, Baoquan Han, Wenting Li, Bin Jiang, Kaoyuan Zhang, Xingling Jian, Zhenzhen Chen, Hui Li, Haiyan Huang, Xia Dou, Bo Yu
Cell & Bioscience.2023;[Epub] CrossRef
Cutibacterium acnes Dysbiosis: Alternative Therapeutics for Clinical Application
Sara Sá, Ruben Fernandes, Álvaro Gestoso, José Mário Macedo, Daniela Martins-Mendes, Ana Cláudia Pereira, Pilar Baylina
Applied Sciences.2023; 13(21): 12086. CrossRef

First
Prev
Page of 1
Next
Last

Search